APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dermatology OTC Medications

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

Selected research

Market Structure

Global Dermatology OTC Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchDermatology OTC Medications Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatology OTC Medications Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Dermatology OTC Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatology OTC Medications Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatology OTC Medications Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.

This report provides an overview of the global Dermatology OTC Medications market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Dermatology OTC Medications and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dermatology OTC Medications sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dermatology OTC Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Dermatology OTC Medications Segment by Company

Bayer

GSK

Teva

Johnson & Johnson

Novartis

Mylan

Sun Pharmaceutical

Aurobindo

Galderma

CR SANJIU

Dr. Reddy's

Lupin

Bausch Health

Cipla

Qilu Pharmaceutical

Almirall

Lingrui

Dermatology OTC Medications Segment by Type

External Use

Oral

Dermatology OTC Medications Segment by Application

Hospital

Drug Store

Other

Dermatology OTC Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatology OTC Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatology OTC Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatology OTC Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dermatology OTC Medications market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dermatology OTC Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dermatology OTC Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dermatology OTC Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dermatology OTC Medications Industry Trends Table 2. Dermatology OTC Medications Industry Drivers Table 3. Dermatology OTC Medications Industry Opportunities and Challenges Table 4. Dermatology OTC Medications Industry Restraints Table 5. Global Dermatology OTC Medications Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dermatology OTC Medications Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dermatology OTC Medications Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Dermatology OTC Medications Sales Market Share by Manufacturers Table 9. Global Dermatology OTC Medications Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Dermatology OTC Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dermatology OTC Medications Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dermatology OTC Medications Manufacturers, Product Type & Application Table 13. Global Dermatology OTC Medications Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dermatology OTC Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of External Use Table 17. Major Manufacturers of Oral Table 18. Global Dermatology OTC Medications Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 19. Global Dermatology OTC Medications Sales by Type (2021-2026) & (M Units) Table 20. Global Dermatology OTC Medications Sales by Type (2027-2032) & (M Units) Table 21. Global Dermatology OTC Medications Sales Market Share by Type (2021-2026) Table 22. Global Dermatology OTC Medications Sales Market Share by Type (2027-2032) Table 23. Global Dermatology OTC Medications Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 24. Global Dermatology OTC Medications Revenue by Type (2021-2026) & (M Units) Table 25. Global Dermatology OTC Medications Revenue by Type (2027-2032) & (M Units) Table 26. Global Dermatology OTC Medications Revenue Market Share by Type (2021-2026) Table 27. Global Dermatology OTC Medications Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Drug Store Table 30. Major Manufacturers of Other Table 31. Global Dermatology OTC Medications Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 32. Global Dermatology OTC Medications Sales by Application (2021-2026) & (M Units) Table 33. Global Dermatology OTC Medications Sales by Application (2027-2032) & (M Units) Table 34. Global Dermatology OTC Medications Sales Market Share by Application (2021-2026) Table 35. Global Dermatology OTC Medications Sales Market Share by Application (2027-2032) Table 36. Global Dermatology OTC Medications Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 37. Global Dermatology OTC Medications Revenue by Application (2021-2026) & (M Units) Table 38. Global Dermatology OTC Medications Revenue by Application (2027-2032) & (M Units) Table 39. Global Dermatology OTC Medications Revenue Market Share by Application (2021-2026) Table 40. Global Dermatology OTC Medications Revenue Market Share by Application (2027-2032) Table 41. Global Dermatology OTC Medications Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 42. Global Dermatology OTC Medications Sales by Region (2021-2026) & (M Units) Table 43. Global Dermatology OTC Medications Sales Market Share by Region (2021-2026) Table 44. Global Dermatology OTC Medications Sales Forecasted by Region (2027-2032) & (M Units) Table 45. Global Dermatology OTC Medications Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Dermatology OTC Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 47. North America Dermatology OTC Medications Sales by Country (2021-2026) & (M Units) Table 48. North America Dermatology OTC Medications Sales by Country (2027-2032) & (M Units) Table 49. Europe Dermatology OTC Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 50. Europe Dermatology OTC Medications Sales by Country (2021-2026) & (M Units) Table 51. Europe Dermatology OTC Medications Sales by Country (2027-2032) & (M Units) Table 52. Asia Pacific Dermatology OTC Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. Asia Pacific Dermatology OTC Medications Sales by Country (2021-2026) & (M Units) Table 54. Asia Pacific Dermatology OTC Medications Sales by Country (2027-2032) & (M Units) Table 55. South America, Middle East and Africa Dermatology OTC Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. South America, Middle East and Africa Dermatology OTC Medications Sales by Country (2021-2026) & (M Units) Table 57. South America, Middle East and Africa Dermatology OTC Medications Sales by Country (2027-2032) & (M Units) Table 58. Global Dermatology OTC Medications Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Dermatology OTC Medications Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Dermatology OTC Medications Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Dermatology OTC Medications Revenue Market Share by Region (2021-2026) Table 62. Global Dermatology OTC Medications Revenue Market Share by Region (2027-2032) Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bayer Dermatology OTC Medications Product Portfolio Table 67. Bayer Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GSK Dermatology OTC Medications Product Portfolio Table 72. GSK Recent Development Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Teva Dermatology OTC Medications Product Portfolio Table 77. Teva Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Dermatology OTC Medications Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Novartis Dermatology OTC Medications Product Portfolio Table 87. Novartis Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Mylan Dermatology OTC Medications Product Portfolio Table 92. Mylan Recent Development Table 93. Sun Pharmaceutical Company Information Table 94. Sun Pharmaceutical Business Overview Table 95. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sun Pharmaceutical Dermatology OTC Medications Product Portfolio Table 97. Sun Pharmaceutical Recent Development Table 98. Aurobindo Company Information Table 99. Aurobindo Business Overview Table 100. Aurobindo Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Aurobindo Dermatology OTC Medications Product Portfolio Table 102. Aurobindo Recent Development Table 103. Galderma Company Information Table 104. Galderma Business Overview Table 105. Galderma Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Galderma Dermatology OTC Medications Product Portfolio Table 107. Galderma Recent Development Table 108. CR SANJIU Company Information Table 109. CR SANJIU Business Overview Table 110. CR SANJIU Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. CR SANJIU Dermatology OTC Medications Product Portfolio Table 112. CR SANJIU Recent Development Table 113. Dr. Reddy's Company Information Table 114. Dr. Reddy's Business Overview Table 115. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Dr. Reddy's Dermatology OTC Medications Product Portfolio Table 117. Dr. Reddy's Recent Development Table 118. Lupin Company Information Table 119. Lupin Business Overview Table 120. Lupin Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Lupin Dermatology OTC Medications Product Portfolio Table 122. Lupin Recent Development Table 123. Bausch Health Company Information Table 124. Bausch Health Business Overview Table 125. Bausch Health Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Bausch Health Dermatology OTC Medications Product Portfolio Table 127. Bausch Health Recent Development Table 128. Cipla Company Information Table 129. Cipla Business Overview Table 130. Cipla Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Cipla Dermatology OTC Medications Product Portfolio Table 132. Cipla Recent Development Table 133. Qilu Pharmaceutical Company Information Table 134. Qilu Pharmaceutical Business Overview Table 135. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Qilu Pharmaceutical Dermatology OTC Medications Product Portfolio Table 137. Qilu Pharmaceutical Recent Development Table 138. Almirall Company Information Table 139. Almirall Business Overview Table 140. Almirall Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Almirall Dermatology OTC Medications Product Portfolio Table 142. Almirall Recent Development Table 143. Lingrui Company Information Table 144. Lingrui Business Overview Table 145. Lingrui Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Lingrui Dermatology OTC Medications Product Portfolio Table 147. Lingrui Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Dermatology OTC Medications Distributors List Table 151. Dermatology OTC Medications Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Dermatology OTC Medications Product Image Figure 2. Global Dermatology OTC Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dermatology OTC Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Dermatology OTC Medications Sales (2021-2032) & (M Units) Figure 5. Global Dermatology OTC Medications Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dermatology OTC Medications Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. External Use Image Figure 9. Oral Image Figure 10. Global Dermatology OTC Medications Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 11. Global Dermatology OTC Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Dermatology OTC Medications Sales Market Share by Type (2021-2032) Figure 13. Global Dermatology OTC Medications Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global Dermatology OTC Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dermatology OTC Medications Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Drug Store Image Figure 18. Other Image Figure 19. Global Dermatology OTC Medications Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 20. Global Dermatology OTC Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Dermatology OTC Medications Sales Market Share by Application (2021-2032) Figure 22. Global Dermatology OTC Medications Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global Dermatology OTC Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Dermatology OTC Medications Revenue Market Share by Application (2021-2032) Figure 25. North America Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 26. North America Dermatology OTC Medications Sales Market Share by Country (2021-2032) Figure 27. U.S. Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 28. Canada Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 29. Mexico Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Europe Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Europe Dermatology OTC Medications Sales Market Share by Country (2021-2032) Figure 32. Germany Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 33. France Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 34. U.K. Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Italy Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Netherlands Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Asia Pacific Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Asia Pacific Dermatology OTC Medications Sales Market Share by Country (2021-2032) Figure 39. China Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Japan Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 41. South Korea Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Southeast Asia Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 43. India Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Australia Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 45. South America, Middle East and Africa Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 46. South America, Middle East and Africa Dermatology OTC Medications Sales Market Share by Country (2021-2032) Figure 47. Brazil Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South Africa Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 49. Saudi Arabia Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Turkey Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Argentina Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 52. UAE Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Egypt Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Chile Dermatology OTC Medications Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Global Dermatology OTC Medications Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Dermatology OTC Medications Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Dermatology OTC Medications Revenue (2021-2032) & (US$ Million) Figure 58. North America Dermatology OTC Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Dermatology OTC Medications Revenue (2021-2032) & (US$ Million) Figure 60. Europe Dermatology OTC Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Dermatology OTC Medications Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Dermatology OTC Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Dermatology OTC Medications Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Dermatology OTC Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Dermatology OTC Medications Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Dermatology OTC Medications Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • External Use
  • Oral
Applications
  • Hospital
  • Drug Store
  • Other
Companies covered
  • Bayer
  • GSK
  • Teva
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Sun Pharmaceutical
  • Aurobindo
  • Galderma
  • CR SANJIU
  • Dr. Reddy's
  • Lupin
  • Bausch Health
  • Cipla
  • Qilu Pharmaceutical
  • Almirall
  • Lingrui

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dermatology OTC Medications Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dermatology OTC Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dermatology OTC Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dermatology OTC Medications Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dermatology OTC Medications Market Dynamics
  1. 2.1 Dermatology OTC Medications Industry Trends
  2. 2.2 Dermatology OTC Medications Industry Drivers
  3. 2.3 Dermatology OTC Medications Industry Opportunities and Challenges
  4. 2.4 Dermatology OTC Medications Industry Restraints
3 Dermatology OTC Medications Market by Manufacturers
  1. 3.1 Global Dermatology OTC Medications Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dermatology OTC Medications Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dermatology OTC Medications Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dermatology OTC Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dermatology OTC Medications Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dermatology OTC Medications Manufacturers, Product Type & Application
  7. 3.7 Global Dermatology OTC Medications Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dermatology OTC Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dermatology OTC Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dermatology OTC Medications Tier 1, Tier 2, and Tier 3
4 Dermatology OTC Medications Market by Type
  1. 4.1 Dermatology OTC Medications Type Introduction
  2. 4.1.1 External Use
  3. 4.1.2 Oral
  4. 4.2 Global Dermatology OTC Medications Sales by Type
  5. 4.2.1 Global Dermatology OTC Medications Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dermatology OTC Medications Sales by Type (2021-2032)
  7. 4.2.3 Global Dermatology OTC Medications Sales Market Share by Type (2021-2032)
  8. 4.3 Global Dermatology OTC Medications Revenue by Type
  9. 4.3.1 Global Dermatology OTC Medications Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dermatology OTC Medications Revenue by Type (2021-2032)
  11. 4.3.3 Global Dermatology OTC Medications Revenue Market Share by Type (2021-2032)
5 Dermatology OTC Medications Market by Application
  1. 5.1 Dermatology OTC Medications Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.1.3 Other
  5. 5.2 Global Dermatology OTC Medications Sales by Application
  6. 5.2.1 Global Dermatology OTC Medications Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dermatology OTC Medications Sales by Application (2021-2032)
  8. 5.2.3 Global Dermatology OTC Medications Sales Market Share by Application (2021-2032)
  9. 5.3 Global Dermatology OTC Medications Revenue by Application
  10. 5.3.1 Global Dermatology OTC Medications Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dermatology OTC Medications Revenue by Application (2021-2032)
  12. 5.3.3 Global Dermatology OTC Medications Revenue Market Share by Application (2021-2032)
6 Global Dermatology OTC Medications Sales by Region
  1. 6.1 Global Dermatology OTC Medications Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dermatology OTC Medications Sales by Region (2021-2032)
  3. 6.2.1 Global Dermatology OTC Medications Sales by Region (2021-2026)
  4. 6.2.2 Global Dermatology OTC Medications Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dermatology OTC Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dermatology OTC Medications Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dermatology OTC Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dermatology OTC Medications Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dermatology OTC Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dermatology OTC Medications Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dermatology OTC Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dermatology OTC Medications Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dermatology OTC Medications Revenue by Region
  1. 7.1 Global Dermatology OTC Medications Revenue by Region
  2. 7.1.1 Global Dermatology OTC Medications Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dermatology OTC Medications Revenue by Region (2021-2026)
  4. 7.1.3 Global Dermatology OTC Medications Revenue by Region (2027-2032)
  5. 7.1.4 Global Dermatology OTC Medications Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dermatology OTC Medications Revenue (2021-2032)
  8. 7.2.2 North America Dermatology OTC Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dermatology OTC Medications Revenue (2021-2032)
  11. 7.3.2 Europe Dermatology OTC Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dermatology OTC Medications Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dermatology OTC Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dermatology OTC Medications Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dermatology OTC Medications Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bayer Dermatology OTC Medications Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK Dermatology OTC Medications Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Teva
  14. 8.3.1 Teva Company Information
  15. 8.3.2 Teva Business Overview
  16. 8.3.3 Teva Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Dermatology OTC Medications Product Portfolio
  18. 8.3.5 Teva Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Dermatology OTC Medications Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Dermatology OTC Medications Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Dermatology OTC Medications Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Sun Pharmaceutical
  38. 8.7.1 Sun Pharmaceutical Company Information
  39. 8.7.2 Sun Pharmaceutical Business Overview
  40. 8.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sun Pharmaceutical Dermatology OTC Medications Product Portfolio
  42. 8.7.5 Sun Pharmaceutical Recent Developments
  43. 8.8 Aurobindo
  44. 8.8.1 Aurobindo Company Information
  45. 8.8.2 Aurobindo Business Overview
  46. 8.8.3 Aurobindo Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Aurobindo Dermatology OTC Medications Product Portfolio
  48. 8.8.5 Aurobindo Recent Developments
  49. 8.9 Galderma
  50. 8.9.1 Galderma Company Information
  51. 8.9.2 Galderma Business Overview
  52. 8.9.3 Galderma Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Galderma Dermatology OTC Medications Product Portfolio
  54. 8.9.5 Galderma Recent Developments
  55. 8.10 CR SANJIU
  56. 8.10.1 CR SANJIU Company Information
  57. 8.10.2 CR SANJIU Business Overview
  58. 8.10.3 CR SANJIU Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CR SANJIU Dermatology OTC Medications Product Portfolio
  60. 8.10.5 CR SANJIU Recent Developments
  61. 8.11 Dr. Reddy's
  62. 8.11.1 Dr. Reddy's Company Information
  63. 8.11.2 Dr. Reddy's Business Overview
  64. 8.11.3 Dr. Reddy's Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dr. Reddy's Dermatology OTC Medications Product Portfolio
  66. 8.11.5 Dr. Reddy's Recent Developments
  67. 8.12 Lupin
  68. 8.12.1 Lupin Company Information
  69. 8.12.2 Lupin Business Overview
  70. 8.12.3 Lupin Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lupin Dermatology OTC Medications Product Portfolio
  72. 8.12.5 Lupin Recent Developments
  73. 8.13 Bausch Health
  74. 8.13.1 Bausch Health Company Information
  75. 8.13.2 Bausch Health Business Overview
  76. 8.13.3 Bausch Health Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bausch Health Dermatology OTC Medications Product Portfolio
  78. 8.13.5 Bausch Health Recent Developments
  79. 8.14 Cipla
  80. 8.14.1 Cipla Company Information
  81. 8.14.2 Cipla Business Overview
  82. 8.14.3 Cipla Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cipla Dermatology OTC Medications Product Portfolio
  84. 8.14.5 Cipla Recent Developments
  85. 8.15 Qilu Pharmaceutical
  86. 8.15.1 Qilu Pharmaceutical Company Information
  87. 8.15.2 Qilu Pharmaceutical Business Overview
  88. 8.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Qilu Pharmaceutical Dermatology OTC Medications Product Portfolio
  90. 8.15.5 Qilu Pharmaceutical Recent Developments
  91. 8.16 Almirall
  92. 8.16.1 Almirall Company Information
  93. 8.16.2 Almirall Business Overview
  94. 8.16.3 Almirall Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Almirall Dermatology OTC Medications Product Portfolio
  96. 8.16.5 Almirall Recent Developments
  97. 8.17 Lingrui
  98. 8.17.1 Lingrui Company Information
  99. 8.17.2 Lingrui Business Overview
  100. 8.17.3 Lingrui Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Lingrui Dermatology OTC Medications Product Portfolio
  102. 8.17.5 Lingrui Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dermatology OTC Medications Value Chain Analysis
  2. 9.1.1 Dermatology OTC Medications Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dermatology OTC Medications Production Mode & Process
  6. 9.2 Dermatology OTC Medications Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dermatology OTC Medications Distributors
  9. 9.2.3 Dermatology OTC Medications Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst